Literature DB >> 9488672

Histidine-proline-rich glycoprotein as a plasma pH sensor. Modulation of its interaction with glycosaminoglycans by ph and metals.

D B Borza1, W T Morgan.   

Abstract

The middle domain of plasma histidine-proline-rich glycoprotein (HPRG) contains unusual tandem pentapeptide repeats (consensus G(H/P)(H/P)PH) and binds heparin and transition metals. Unlike other proteins that interact with heparin via lysine or arginine residues, HPRG relies exclusively on histidine residues for this interaction. To assess the consequences of this unusual requirement, we have studied the interaction between human plasma HPRG and immobilized glycosaminoglycans (GAGs) using resonant mirror biosensor techniques. HPRG binding to immobilized heparin was strikingly pH-sensitive, producing a titration curve with a midpoint at pH 6.8. There was little binding of HPRG to heparin at physiological pH in the absence of metals, but the interaction was promoted by nanomolar concentrations of free zinc and copper, and its pH dependence was shifted toward alkaline pH by zinc. The affinity of HPRG for various GAGs measured in a competition assay decreased in the following order: heparin > dermatan sulfate > heparan sulfate > chondroitin sulfate A. Binding of HPRG to immobilized dermatan sulfate had a midpoint at pH 6.5, was less influenced by zinc, and exhibited cooperativity. Importantly, plasminogen interacted specifically with GAG-bound HPRG. We propose that HPRG is a physiological pH sensor, interacting with negatively charged GAGs on cell surfaces only when it acquires a net positive charge by protonation and/or metal binding. This provides a mechanism to regulate the function of HPRG (the local pH) and rationalizes the role of its unique, conserved histidine-proline-rich domain. Thus, under conditions of local acidosis (e.g. ischemia or hypoxia), HPRG can co-immobilize plasminogen at the cell surface as well as compete for heparin with other proteins such as antithrombin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488672     DOI: 10.1074/jbc.273.10.5493

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Histidine-Rich Glycoprotein Inhibits HIV-1 Infection in a pH-Dependent Manner.

Authors:  Juan Sabatté; Jorge Geffner; Ezequiel Dantas; Fernando Erra Díaz; Pehuén Pereyra Gerber; Augusto Varese; Diana Alicia Jerusalinsky; Alberto L Epstein; Hernán J García Rivello; Ana Del Valle Jaén; Julieta B Pandolfi; Ana Ceballos; Matias Ostrowski
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II.

Authors:  Matthew Ndonwi; Oname O Burlingame; Aaron S Miller; Douglas M Tollefsen; George J Broze; Daniel E Goldberg
Journal:  Blood       Date:  2011-04-21       Impact factor: 22.113

3.  A pH-sensitive heparin-binding sequence from Baculovirus gp64 protein is important for binding to mammalian cells but not to Sf9 insect cells.

Authors:  Chunxiao Wu; Shu Wang
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

4.  Zn2+ mediates high affinity binding of heparin to the αC domain of fibrinogen.

Authors:  James C Fredenburgh; Beverly A Leslie; Alan R Stafford; Teresa Lim; Howard H Chan; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

5.  Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the gamma'-chain.

Authors:  Trang T Vu; Alan R Stafford; Beverly A Leslie; Paul Y Kim; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

6.  Plasmodium falciparum histidine rich protein HRPII inhibits the anti-inflammatory function of antithrombin.

Authors:  Peyman Dinarvand; Likui Yang; Indranil Biswas; Hemant Giri; Alireza R Rezaie
Journal:  J Thromb Haemost       Date:  2020-01-14       Impact factor: 5.824

7.  Monitoring of heparin and its low-molecular-weight analogs by silicon field effect.

Authors:  Nebojsa M Milovic; Jonathan R Behr; Michel Godin; Chih-Sheng Johnson Hou; Kristofor R Payer; Aarthi Chandrasekaran; Peter R Russo; Ram Sasisekharan; Scott R Manalis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

8.  Postinjury hyperfibrinogenemia compromises efficacy of heparin-based venous thromboembolism prophylaxis.

Authors:  Jeffrey N Harr; Ernest E Moore; Theresa L Chin; Arsen Ghasabyan; Eduardo Gonzalez; Max V Wohlauer; Angela Sauaia; Anirban Banerjee; Christopher C Silliman
Journal:  Shock       Date:  2014-01       Impact factor: 3.454

9.  Histidine-rich glycoprotein prevents the formation of insoluble immune complexes by rheumatoid factor.

Authors:  N N Gorgani; J G Altin; C R Parish
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

10.  Structural characterization of the E2 domain of APL-1, a Caenorhabditis elegans homolog of human amyloid precursor protein, and its heparin binding site.

Authors:  James T Hoopes; Xuying Liu; Xiaomeng Xu; Borries Demeler; Ewa Folta-Stogniew; Chris Li; Ya Ha
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.